United States · Exchanges & live quotes · Nasdaq
Johnson & Johnson To Acquire Ollin Biosciences In $2.2 Bln Deal
Detailed summary
(RTTNews) - Healthcare company Johnson & Johnson (JNJ) announced on Monday that it has agreed to acquire clinical-stage biopharmaceutical company Ollin Biosciences for $2.2…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)


